Conference Detail Page

Can We Talk: Strategies to Communicate Long-Acting Injectables (LAIs) as an Effective Treatment Option for Bipolar I Disorder

CME : 0.5 +3
Start Date :  Nov 19 - 2020 End Date :  Nov 19 - 2021

Organized by :   CME Outfitters, LLC

Specialities :   Psychiatry

Conference Summary

Can We Talk: Strategies to Communicate Long-Acting Injectables (LAIs) as an Effective Treatment Option for Bipolar I Disorder is organized by CME Outfitters, LLC.

Premiere Date: Thursday, November 19, 2020
Credit Expiration Date: Friday, November 19, 2021

Accreditation:
CME Credit (Physicians):

CME Outfitters, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hours (0.05 CEUs)

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. 

Note to PAs: PAs may claim a maximum of .5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Statement of Need
Bipolar I disorder (BD-I) is an often chronic, debilitating condition in which medication is a mainstay of treatment. However, medication non adherence can negatively impact clinical outcomes, increasing the risk for relapse and (re)hospitalization. Long-acting injectables (LAIs), particularly relative to oral therapies, are an effective treatment option for BD-I that overcomes nonadherence, thereby promoting remission and functional recovery. However, despite their safety and efficacy, both clinician and patient factors impede their use in routine practice.

This CME Outfitters BriefCase utilizes a patient case to guide clinicians on best practices to engage patients in treatment planning for BD-I, including the feasibility of LAIs as an effective treatment option.

Learning Objectives:
At the end of this CE activity, participants should be able to:
• Incorporate collaborative care discussions with patients with bipolar I disorder that include incorporating LAIs as a potential management option.

The following learning objectives pertain only to those requesting CNE or CPE credit:
• Describe ways to incorporate collaborative care discussions with patients with bipolar I disorder that include incorporating LAIs as a potential management option.

Topic
End of life care
End of life carePatient safety
Patient safety
Credit Info

  • CME : 0.5
  • Contact Hours : 0.5
  • CEUs : 0.05
  • MOC : 0.5
Target Audience

Psychiatrists, primary care physicians, PAs, nurse practitioners, nurses, and pharmacists

Peers Info
Number of Health Care Professionals Registered: 0 Number
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat